OTC Healthcare in Croatia
Euromonitor International's OTC Healthcare in Croatia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 99 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Growth continues backed by extensive advertising
The growth trend continued in 2008, with current value growth growing at a faster rate than the review period CAGR. Higher growth was partly driven by inflation rate in Croatia. The advertising of OTC Healthcare products was ubiquitous. Leading players such as Pliva dd and GlaxoSmithKline doo were the most active advertisers. Other major players such as Bayer Pharma doo, Belupo lijekovi i kozmetika dd
or Krka-Farma doo. Advertising campaigns boosted the awareness of OTC alternatives, and chemists/pharmacies in Croatia enjoyed positive turnover in 2008.
Customers demand faster and stronger acting products
Modern lifestyles are increasingly hectic and the Croatian working population is more overwhelmed by responsibilities and duties than ever before. It has even become common for an employee to claim that he/she is ill and under heavy medication, yet still work all day. The public health system is very inefficient and time-consuming, therefore urban consumers tend to put off visiting their doctor for as long as possible. OTC Healthcare offers convenient and quick alternatives. For example, fears of stress and obesity are gaining importance in Croatia, thereby creating the demand for calming and also slimming products.
Domestic player retains leading position
The domestic manufacturer Pliva dd was the leading player in 2008. The company was also the main issue concerning the competitive landscape in OTC Healthcare in Croatia. Pliva, which was purchased by Barr Pharmaceuticals Inc, experienced another change in ownership in 2008, as Teva Pharmaceutical Industries Ltd acquired Barr in July 2008. The bleak global economic outlook also affected the company, making unpopular lay-offs necessary in Pliva’s Croatian, Polish and Czech factories.
The liberalisation of distribution is on the way
The dominance of OTC Healthcare by chemists/pharmacies softened in 2008. DM- Drogerie Markt doo’s pioneering effort to open a special OTC Healthcare department was quickly followed by Atlantic Grupa dd, which has ambitious plans to create a network of parapharmacies all over Croatia. These preparations are in full motion, which means that the forecast period should witness fierce competition between pharmacies and drugstores.
Ambitious development plans continue despite economic slowdown
Although the global economic slowdown is very likely to affect OTC Healthcare sales in Croatia in the short term, manufacturers are confident about sales growth over the forecast period. The economic downturn came at the exact moment that big retailers decided to grab a slice of the OTC Healthcare cake. Despite the economic slowdown, this development should lead to increased sales through innovations and new product launches. The investments in strengthening the parapharmacies/drugstores distribution channel are expected to prevail, thereby growing sales.
Table of contents
OTC HEALTHCARE IN CROATIA : MARKET INSIGHT
EXECUTIVE SUMMARY
Growth continues backed by extensive advertising
Customers demand faster and stronger acting products
Domestic player retains leading position
The liberalisation of distribution is on the way
Ambitious development plans continue despite economic slowdown
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
DEFINITIONS
Summary 1 Research Sources
ANALGESICS
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Analgesics Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 21 Sales of Decongestants by Type: Value 2003-2008
Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 32 Herbal vs Standard Digestive Remedies 2003-2008
Table 33 Digestive Remedies Company Shares by Value 2004-2008
Table 34 Digestive Remedies Brand Shares by Value 2005-2008
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 39 Herbal vs Standard Medicated Skin Care 2003-2008
Table 40 Medicated Skin Care Company Shares by Value 2004-2008
Table 41 Medicated Skin Care Brand Shares by Value 2005-2008
Table 42 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 43 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN CROATIA
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 44 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 46 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 47 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 48 Vitamins Brand Shares by Value 2005-2008
Table 49 Dietary Supplements Brand Shares by Value 2005-2008
Table 50 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS
Headlines
Trends
Switches
Competitive Landscape
Prospects
SECTOR INDICATORS
Table 52 Number of Smokers by Gender 2003-2008
Sector Data
Table 53 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 54 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 55 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 56 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 57 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 58 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE
Headlines
Sector Data
Table 59 Sales of Eye Care by Subsector: Value 2003-2008
Table 60 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 61 Eye Care Company Shares by Value 2004-2008
Table 62 Eye Care Brand Shares by Value 2005-2008
Table 63 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 64 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
WOUND TREATMENTS
Sector Data
Table 65 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 66 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 67 Wound Treatments Company Shares by Value 2004-2008
Table 68 Wound Treatments Brand Shares by Value 2005-2008
Table 69 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 70 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
EAR CARE
Headlines
Sector Data
Table 71 Sales of Ear Care: Value 2003-2008
Table 72 Sales of Ear Care: % Value Growth 2003-2008
Table 73 Ear Care Company Shares by Value 2004-2008
Table 74 Ear Care Brand Shares by Value 2005-2008
Table 75 Forecast Sales of Ear Care: Value 2008-2013
Table 76 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE
Headlines
Sector Data
Table 77 Sales of Adult Mouth Care: Value 2003-2008
Table 78 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 79 Adult Mouth Care Company Shares by Value 2004-2008
Table 80 Adult Mouth Care Brand Shares by Value 2005-2008
Table 81 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 82 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS
Headlines
Sector Data
Table 83 Sales of Calming and Sleeping Products: Value 2003-2008
Table 84 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 85 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 86 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 87 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 88 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
EMERGENCY CONTRACEPTION
Headlines
BELUPO DD
Strategic Direction
Key Facts
Summary 2 Belupo dd: Key Facts
Summary 3 Belupo dd: Operational Indicators
Company Background
Production
Summary 4 Belupo dd: Production Statistics 2008
Competitive Positioning
Summary 5 Belupo dd: Competitive Position 2008
JADRAN GALENSKI LABORATORIJ
Strategic Direction
Key Facts
Summary 6 Jadran Galenski Laboratorij: Key Facts
Summary 7 Jadran Galenski Laboratorij: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Jadran Galenski Laboratorij: Competitive Position 2007
PLIVA DD
Strategic Direction
Key Facts
Summary 9 Pliva dd: Key Facts
Summary 10 Pliva dd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Pliva dd: Competitive Position 2008